Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy - Bilitranslocase

被引:40
|
作者
Passamonti, S
Terdoslavich, M
Margon, A
Cocolo, A
Medic, N
Micali, F
Decorti, G
Franko, M
机构
[1] Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy
[2] Univ Trieste, Dipartimento Sci Biomed, Trieste, Italy
关键词
bilirubin; bilitranslocase; HepG2; cells; thermal lens spectrometry; uptake assay;
D O I
10.1111/j.1742-4658.2005.04949.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bilitranslocase is a carrier protein localized at the basolateral domain of the hepatocyte plasma membrane. It transports various organic anions, including bromosulfophthalein and anthocyanins. Functional studies in subcellular fractions enriched in plasma membrane revealed a high-affinity binding site for bilirubin, associated with bilitranslocase. The aim of this work was to test whether the liver uptake of bilirubin depends on the activity of bilitranslocase. To this purpose, an assay of bilirubin uptake into HepG2 cell cultures was set up. The transport assay medium contained bilirubin at a concentration of approximate to 50 nM in the absence of albumin. To analyse the relative changes in bilirubin concentration in the medium throughout the uptake experiment, a highly sensitive thermal lens spectrometry method was used. The mechanism of bilirubin uptake into HepG2 cells was investigated by using inhibitors such as anti-sequence bilitranslocase antibodies, the protein-modifying reagent phenylmethanesulfonyl fluoride and diverse organic anions, including nicotinic acid, taurocholate and digoxin. To validate the assay further, both bromosulfophthalein and indocyanine green uptake in HepG2 cells was also characterized. The results obtained show that bilitranslocase is a carrier with specificity for both bilirubin and bromosulfophthalein, but not for indocyanine green.
引用
收藏
页码:5522 / 5535
页数:14
相关论文
共 50 条
  • [31] Cellular uptake, elimination and toxicity of CdSe/ZnS quantum dots in HepG2 cells
    Peng, Lu
    He, Man
    Chen, Beibei
    Wu, Qiumei
    Zhang, Zhiling
    Pang, Daiwen
    Zhu, Ying
    Hu, Bin
    BIOMATERIALS, 2013, 34 (37) : 9545 - 9558
  • [32] Phenolic compounds ameliorate the glucose uptake in HepG2 cells' insulin resistance via activating AMPK Anti-diabetic effect of phenolic compounds in HepG2 cells
    Huang, Qun
    Chen, Lei
    Teng, Hui
    Song, Hongbo
    Wu, Xiaoqi
    Xu, Meiyu
    JOURNAL OF FUNCTIONAL FOODS, 2015, 19 : 487 - 494
  • [33] Cellular and molecular aspects of thiamin uptake by human liver cells: studies with cultured HepG2 cells
    Said, HM
    Reidling, JC
    Ortiz, A
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1567 (1-2): : 106 - 112
  • [34] Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells
    Westerink, Walter M. A.
    Schoonen, Willem G. E. J.
    TOXICOLOGY IN VITRO, 2007, 21 (08) : 1592 - 1602
  • [35] HCV cDNA transfection to HepG2 cells
    Hiramatsu, N
    Dash, S
    Gerber, MA
    JOURNAL OF VIRAL HEPATITIS, 1997, 4 : 61 - 67
  • [36] MITOCHONDRIAL TOXICITY OF CHLOROACETALDEHYDE IN HEPG2 CELLS
    Falkner, Keith C.
    Hill, Bradford G.
    Sansbury, Brian
    McClain, Craig J.
    Cave, Matthew C.
    HEPATOLOGY, 2010, 52 (04) : 455A - 456A
  • [37] The aptamers generated from HepG2 cells
    Rongrong Huang
    Zhongsi Chen
    Mei Liu
    Yan Deng
    Song Li
    Nongyue He
    Science China(Chemistry), 2017, 60 (06) : 786 - 792
  • [38] The aptamers generated from HepG2 cells
    Rongrong Huang
    Zhongsi Chen
    Mei Liu
    Yan Deng
    Song Li
    Nongyue He
    Science China(Chemistry), 2017, (06) : 786 - 792
  • [39] REGULATION OF SQUALENE EPOXIDASE IN HEPG2 CELLS
    HIDAKA, Y
    SATOH, T
    KAMEI, T
    JOURNAL OF LIPID RESEARCH, 1990, 31 (11) : 2087 - 2094
  • [40] Isocryptolepine, an indoloquinoline alkaloid from Cryptolepis sanguinolenta promotes LDL uptake in HepG2 cells
    Mike Okweesi Aggrey
    Hui-Hui Li
    Wen-Qiong Wang
    Weibin Song
    Yiping Wang
    Li-Jiang Xuan
    Revista Brasileira de Farmacognosia, 2018, 28 : 654 - 657